Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

References

• DetterbeckFCBoffaDJTanoueLTThe new lung cancer staging systemChest2009136126027119584208
   PubMed Web of Science ®Google Scholar
• GoldstrawPChanskyKCrowleyJInternational Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating InstitutionsThe IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerJ Thorac Oncol2016111395126762738
   PubMed Web of Science ®Google Scholar
• SocinskiMABogartJALimited-stage small-cell lung cancer: the current status of combined-modality therapyJ Clin Oncol200725264137414517827464
   PubMed Web of Science ®Google Scholar
• van MeerbeeckJPFennellDADe RuysscherDKSmall-cell lung cancerLancet201137898041741175521565397
   PubMed Web of Science ®Google Scholar
• JettJRSchildSEKeslerKAKalemkerianGPTreatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest20131435 Supple400Se419S23649448
   PubMed Web of Science ®Google Scholar
• GazdarAFBunnPAMinnaJDSmall-cell lung cancer: what we know, what we need to know and the path forwardNat Rev Cancer2017171272573729077690
   PubMed Web of Science ®Google Scholar
• TakadaMFukuokaMKawaharaMPhase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104J Clin Oncol200220143054306012118018
   PubMed Web of Science ®Google Scholar
• De RuysscherDPijls-JohannesmaMBentzenSMTime between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancerJ Clin Oncol20062471057106316505424
   PubMed Web of Science ®Google Scholar
• NodaKNishiwakiYKawaharaMJapan Clinical Oncology GroupIrinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancerN Engl J Med20023462859111784874
   PubMed Web of Science ®Google Scholar
• HannaNBunnPAJrLangerCRandomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancerJ Clin Oncol200624132038204316648503
   PubMed Web of Science ®Google Scholar
• SundstrømSBremnesRMKaasaSNorwegian Lung Cancer Study GroupCisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-upJ Clin Oncol200220244665467212488411
   PubMed Web of Science ®Google Scholar
• GasparLEGayEGCrawfordJPutnamJBHerbstRSBonnerJALimited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data BaseClin Lung Cancer20056635536015943896
   PubMedGoogle Scholar
• GovindanRPageNMorgenszternDChanging epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results databaseJ Clin Oncol200624284539454417008692
   PubMed Web of Science ®Google Scholar
• FosterNRMandrekarSJSchildSEPrognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trialsCancer2009115122721273119402175
   PubMed Web of Science ®Google Scholar
• FieglMPircherAWaldthalerCSmall steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patientsLung Cancer201484216817424646832
   PubMed Web of Science ®Google Scholar
• SlotmanBFaivre-FinnCKramerGProphylactic cranial irradiation in extensive small-cell lung cancerN Engl J Med200735766467217699816
   PubMed Web of Science ®Google Scholar
• SlotmanBJvan TinterenHWhich patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?Transl Lung Cancer Res20154329229426207217
   PubMedGoogle Scholar
• NosakiKSetoTThe Role of Radiotherapy in the Treatment of Small-Cell Lung CancerCurr Treat Options Oncol201516125626467930
   PubMed Web of Science ®Google Scholar
• EberhardtWEMitchellACrowleyJInternational Association for Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions.The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung CancerJ Thorac Oncol201510111515152226536193
   PubMed Web of Science ®Google Scholar
• HellmanSWeichselbaumRROligometastasesJ Clin Oncol19951318107799047
   PubMed Web of Science ®Google Scholar
• NicholsonAGChanskyKCrowleyJStaging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; Staging and Prognostic Factors Committee Advisory Boards and Participating InstitutionsThe International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung CancerJ Thorac Oncol201611330031126723244
   PubMed Web of Science ®Google Scholar
• LiJZhaoYLiCZhuLLiuCLiuLThe revision of 8th edition TNM stage criteria is more accurate in prediction postoperative survival for SCLC patientsInt J Surg201748838528987562
   PubMed Web of Science ®Google Scholar
• VinjamuriMCraigMCampbell-FontaineAAlmubarakMGuptaNRogersJSCan positron emission tomography be used as a staging tool for small-cell lung cancer?Clin Lung Cancer200891303418282355
   PubMed Web of Science ®Google Scholar
• DayenCDebieuvreDMolinierONew insights into stage and prognosis in small cell lung cancer: an analysis of 968 casesJ Thorac Dis20179125101511129312716
   PubMed Web of Science ®Google Scholar
• AlbainKSCrowleyJJLeBlancMLivingstonRBDeterminants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data baseJ Clin Oncol199089156315742167954
   PubMed Web of Science ®Google Scholar
• AlbainKSCrowleyJJLivingstonRBLong-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experienceChest1991996142514322036826
   PubMed Web of Science ®Google Scholar
• NiibeYChangJYNovel insights of oligometastases and oligorecurrence and review of the literaturePulm Med2012201226109622966429
   PubMedGoogle Scholar
• TsaoMNRadesDWirthARadiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guidelinePract Radiat Oncol20122321022525925626
   PubMedGoogle Scholar
• MehtaMPTsaoMNWhelanTJThe American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastasesInt J Radiat Oncol Biol Phys2005631374616111570
   PubMed Web of Science ®Google Scholar
• ModiAVohraHAWeedenDFDoes surgery for primary non-small cell lung cancer and cerebral metastasis have any impact on survival?Interact Cardiovasc Thorac Surg20098446747319155223
   PubMedGoogle Scholar